IMARC Group has recently released a new research study titled “United States Cancer Diagnostics Market Size, Share, Trends and Forecast by Product, Technology, Application, End User, and Region, 2025-2033” which offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends, and competitive landscape to understand the current and future market scenarios.

Market Overview

The United States cancer diagnostics market size was valued at USD 53 Billion in 2024 and is projected to reach USD 108.2 Billion by 2033, growing at a CAGR of 8.3% during 2025-2033. This growth is driven by the rising prevalence of cancer, development of personalized therapies, and increasing demand for genetic mutation detection. Advanced imaging technologies combined with AI integration are enhancing early detection and treatment personalization in this critical healthcare sector. 

Study Assumption Years

• Base Year: 2024

• Historical Year/Period: 2019-2024

• Forecast Year/Period: 2025-2033

United States Cancer Diagnostics Market Key Takeaways

• Current Market Size: USD 53 Billion in 2024

• CAGR: 8.3% during 2025-2033

• Forecast Period: 2025-2033

• The increasing prevalence of cancer drives the demand for accurate diagnostic tools, improving survival rates via early detection.

• Advances in diagnostic imaging including high-resolution CT, MRI, PET, & 3D mammography facilitate earlier tumor identification.

• Integration of AI in imaging systems is reducing diagnostic errors and supporting radiological decision-making.

• Growing demand for precision medicine and immunotherapies is boosting specific diagnostic tests for personalized treatment.

• Liquid biopsy market is expanding due to its non-invasive nature and real-time monitoring capabilities.

Sample Request Link: https://www.imarcgroup.com/united-states-cancer-diagnostics-market/requestsample